Logos Global Management, LP

Olema Oncology raised $130M on September 5, 2023

Investors: Vivo Capital, Lightspeed Venture Partners, Woodline Partners LP and Logos Global Management, LP

Rapport Therapeutics raised $150M on August 23, 2023

Investors: Surveyor Capital, Goldman Sachs Asset Management, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Third Rock Ventures, Perceptive Advisors and Logos Global Management, LP

COMPASS Pathways raised $125M on August 16, 2023

Investors: Vivo Capital, Soleus Capital Management, L.P., Laurion Capital Management LP, Partner Fund Management, RA Capital Management, L.P., Surveyor Capital, TCG X, Armistice Capital LLC and Logos Global Management, LP

Septerna raised $150M on July 11, 2023

Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, Woodline Partners LP, RA Capital Management, L.P., Soleus Capital Management, L.P., Samsara BioCapital, Vertex Ventures HC and Logos Global Management, LP

Icosavax, Inc. raised $68M on May 22, 2023

Investors: Vivo Capital, TCG X and Logos Global Management, LP

Boundless Bio raised $100M on May 16, 2023

Investors: Nextech Invest, Sectoral Asset Management, Partner Fund Management, Redmile Group, Leaps by Bayer, Surveyor Capital, Vertex Ventures HC, RA Capital Management, L.P., Wellington Management and Logos Global Management, LP

Delcath Systems, Inc raised $85M on March 27, 2023

Investors: Vivo Capital and Logos Global Management, LP

Unicycive Therapeutics raised $30M on March 6, 2023

Investors: Vivo Capital, RA Capital Management, L.P. and Logos Global Management, LP

Entact Bio raised $81M on December 6, 2022

Investors: Qiming Venture Partners USA, Surveyor Capital, venBio Partners, Brandon Capital Partners, Abingworth and Logos Global Management, LP

Odyssey Therapeutics raised $168M on October 13, 2022

Investors: Walleye Capital, SVB Securities, General Catalyst, OrbiMed Advisors, Woodline Partners LP, GreatPoint Ventures, S.R. One Ltd, T. Rowe Price and Logos Global Management, LP